Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

Orbigestrol Tablet

Class 5Status: Registered
Trademark Logo
Application Number4426078
Trademark Status
Registered
Trademark Class5
Application Date2020-01-31
Proprietor NameORB LIFE SCIENCES PRIVATE LIMITED
Appropriate OfficeDELHI
StateUTTAR PRADESH
Trademark TypeDEVICE
User DetailsProposed to be used
Agent NameNEWTON REGINALD[25853]
Agent AddressNo 6, Dhanammal Street Spurtank Road Chetpet Chennai - 600031
Goods And Services Details[CLASS : 5] Pharmaceuticals; Pharmaceutical substances; Pharmaceutical drugs; Pills for pharmaceutical purposes; Pharmaceutical substances and preparations

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about Orbigestrol Tablet.

What is the status of trademark application 4426078?
The current status of trademark application 4426078 for Orbigestrol Tablet is Registered.
What is the trademark class of Orbigestrol Tablet?
Orbigestrol Tablet is registered under trademark class 5.
Who is the proprietor of Orbigestrol Tablet?
The proprietor of Orbigestrol Tablet is ORB LIFE SCIENCES PRIVATE LIMITED.
When was trademark application 4426078 filed?
Trademark application 4426078 for Orbigestrol Tablet was filed on 2020-01-31.